Physician profile
Jonathan D Ralph
NPI 1053596874
$955.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $302 · 2021: $365.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $341.03 | 2019-2021 | |
| Therapeuticsmd, INC. | $133.22 | 2019-2021 | |
| Allergan, INC. | $110.23 | 2019-2020 | |
| Avion Pharmaceuticals | $75.98 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.42 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $45.19 | 2019 | |
| Hologic Sales and Service, LLC | $31.24 | 2019 | |
| Evofem Biosciences, INC. | $22.91 | 2021 | |
| Millicent US INC | $20.55 | 2019 | |
| Minerva Surgical, INC | $20.12 | 2020 | |
| Mayne Pharma Commercial LLC | $19.60 | 2021 | |
| Myovant Sciences INC. | $18.82 | 2021 | |
| Roche Diagnostics Corporation | $15.41 | 2019 | |
| Medicem INC. | $12.40 | 2020 | |
| Mission Pharmacal Company | $11.73 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $10.92 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ralph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.